# Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke

> **NCT06049498** · NA · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 216 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Mongolian Medicine ZhenBao Pills
- **DRUG:** Mongolian Medicine ZhenBao Pills Placebo

## Key facts

- **NCT ID:** NCT06049498
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049498, "Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06049498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*